| Document |
Document Title |
|
WO/2021/094184A1 |
The invention provides a process and a plant for the production of ε-caprolactam and crystalline ammonium sulfate in an industrial-scale plant, wherein the plant comprises a Beckmann rearrangement reaction section, an ammonium sulfate c...
|
|
WO/2021/085653A1 |
The present invention provides an antitumor agent comprising a compound or a pharmaceutically acceptable salt thereof that covalently binds to GTP-bound KRASG12C as an active ingredient.
|
|
WO/2021/067836A1 |
The disclosure provides therapeutic compositions (i.e., therapeutic agents) and methods of preventing or treating Friedreich's ataxia in a mammalian subject, reducing risk factors, signs and/or symptoms associated with Friedreich's ataxi...
|
|
WO/2021/024256A1 |
The invention generally concerns a method for conjugating an active material to a Pt complex.
|
|
WO/2020/245136A1 |
The present invention relates to novel purines of general formula A processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having a...
|
|
WO/2020/212186A1 |
The invention relates to a method for recycling glass fibre reinforced plastic, in particular plastic based on polyamide, polybutylene terephthalate or polyethylene terephthalate, in order to obtain monomers from the polymers as well as ...
|
|
WO/2020/185482A1 |
Method for producing molecular halogen are disclosed, that include the steps of: oxidizing a halide to produce a mixture comprising one or more of a molecular halogen, a trihalide, and a halide; reducing a polysulfide comprising a higher...
|
|
WO/2020/136547A1 |
The present invention refers to a new process for the production of epsilon caprolactam (CPL) from 6-aminocaproic acid (6-ACA) which can be obtained either from traditional petro chemical processes or which can be obtained from biochemic...
|
|
WO/2020/130605A1 |
The present invention relates to a laurolactam preparation method and a synthesis apparatus, and epoxidation and a rearrangement reaction are carried out in the conversion of cyclododecene into cyclododecanone so that the preparation met...
|
|
WO/2020/097363A2 |
Provided herein are compositions and processes for producing compositions from an algae to provide heme and a red or red-like color to edible compositions including ingredients and finished food products. Also provided are methods of gro...
|
|
WO/2019/201569A1 |
A process for preparing dialkyl terephalate comprising the following steps:- i) providing furan-2,5-dicarboxylate; ii) esterifying the furan-2,5-dicarboxylate with alcohol to form furan-2,5-carboxylic acid dialkyl ester; iii) reacting th...
|
|
WO/2019/170538A1 |
The present invention relates to a method for producing an isomer-enriched mixture of 3S- and 3R-caranon of 3-caran epoxide, a 3S-caranon obtained therefrom, a method for producing 3S-caranlactam from 3-carene, a method for producing 3R-...
|
|
WO/2019/117817A1 |
The present invention relates to a process for purifying caprolactam from solutions of crude caprolactam by a direct treatment with one or more alkaline compounds of polyvalent metals, preferably bivalent and trivalent, without resorting...
|
|
WO/2019/081517A2 |
The present invention relates to the two enantiomers of a SElective Glucocorticoid Receptor Agonistic Modulator (SEGRAM) of Formula 1 or a derivative thereof; to a deuterated form of a SEGRAM of Formula 1 or a derivative thereof; and to ...
|
|
WO/2019/025792A1 |
The present invention provides novel, stable, processable and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamineor 2S,6S-hydroxynorketamine with high aqueous solubility.
|
|
WO/2018/162612A1 |
Conversion of organic educts, in particular biomass feedstock, into useful organic compounds via pyrolysis and biocatalysts.
|
|
WO/2018/158620A1 |
The present invention provides processes for the preparation of active pharmaceutical ingredients and intermediates thereof in an aqueous designer smart surfactant solution.
|
|
WO/2018/141771A1 |
The invention relates to a method for producing cyclododecanone (CDON). During the production, contaminated cyclododecane (CDAN) is produced. This can be separated from CDON by distillation (CDAN-containing fraction). The separation of C...
|
|
WO/2018/127379A1 |
The present invention relates to alkylated lactams and their preparation method, notably from renewable resources. It also relates to the use thereof for producing polymers.
|
|
WO/2018/105572A1 |
The present invention is a method for producing ε-caprolactam via adipamide that serves as an intermediate. This method for producing ε-caprolactam is characterized by comprising a lactamization step wherein adipamide produced from a s...
|
|
WO/2018/051869A1 |
This ε-caprolactam production method involves a step in which cyclohexanone oxime is subjected to a Beckmann rearrangement reaction in gas phase in the presence of a zeolite catalyst containing the element silicon and at least one eleme...
|
|
WO/2017/191001A1 |
The present invention relates to new methods for producing cis-alkoxy substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives and new intermediates or starting compounds that are used in the method according to the invention.
|
|
WO/2017/133995A1 |
The present invention relates to a method for producing C4-C15 lactams, in which a C1-C10 alkyl nitrite is reacted with a C4-C15 cycloalkane and is exposed during the reaction by means of a light-emitting diode. The thus produced C4-C15 ...
|
|
WO/2017/043560A1 |
Abstract: Disclosed is a method for producing ε-caprolactam from 3-oxoadipic acid, which is suitable as a biomass resource. The method for producing ε-caprolactam includes a step 1 for mixing at least one selected from the group compri...
|
|
WO/2016/202424A1 |
The present invention relates to optoelectronic devices containing a light absorber which is at least in part inorganic, preferably a perovskite, and polymers (including homopolymers and co-polymers), oligomers or small molecules that ar...
|
|
WO/2016/203069A1 |
The present invention relates to the production of ε-caprolactam by treating cyclohexanone oxime with salts derived from guanidinium cation, and in particular with the tosylate of cyanoguanidine ([CNG][TsO]). The invention of the presen...
|
|
WO/2016/156932A1 |
Disclosed herein is an efficient, economical, industrially advantageous, straight-through process for the preparation of cyclic amides, also referred as lactams, in substantially pure form and high yield, from the corresponding cyclic ke...
|
|
WO/2016/148200A1 |
A method for producing ε-caprolactam wherein the method includes a step (A) for producing cyclohexanone oxime by oxidizing cyclohexylamine and a step (B) for producing ε-caprolactam from the cyclohexanone oxime by a vapor-phase Beckman...
|
|
WO/2016/112814A1 |
A caprolactam preparation method provided in the present invention comprises the following steps: (1) in the presence of an oxime catalyst and absence of any organic solvent, conducting an ammoximation on cyclohexanone, ammonia, and hydr...
|
|
WO/2016/068108A1 |
Disclosed is a method for selectively producing ε-caprolactam from a substance, as a raw material, which can be derived from biomass resources, through a short reaction step while inhibiting production of by-products, and without produc...
|
|
WO/2016/059942A1 |
Provided is a three-phase AC/DC conversion device disposed between a three-phase AC power supply and a light-emitting diode group, the device comprising: a three-phase full-bridge circuit in which pairs of switching elements are connecte...
|
|
WO/2016/014797A1 |
The invention relates to novel compounds and pharmaceutical preparations thereof, as well as methods of making and using these compounds. The invention further relates to methods of treating or preventing disease using the novel compound...
|
|
WO/2016/009442A1 |
The invention discloses a novel method for preparing neuromuscular blocking agents using aryl esters as a reagent of di-acylation as well as highly regioselective mono-acylation of androstane-diols.
|
|
WO/2015/062189A1 |
The present invention relates to a method and apparatus for recovering caprolactam in benzene distillation residue, and provides a method for recovering caprolactam in benzene distillation residue, comprising the following steps: (a) sep...
|
|
WO/2015/061407A1 |
Methods for the synthesis of lactams are presented whereby a carboxylic acid of the formula HOOC------OR---NH-LG, wherein OR is an organic moiety and LG is a leaving group, is reacted with an acid, such as an organic acid, in particular ...
|
|
WO/2015/010885A1 |
Present application discloses an industrial scale continuous process for recovery of caprolactam and crystalline ammonium sulfate. By controlling the weight ratio of the amount of aqueous ammonium sulfate solution being recycled to the a...
|
|
WO/2015/004062A1 |
A process for the recovery of ε-caprolactam from extract water of polycaprolactam obtained by hydrolytic polymerization, wherein the extract water is concentrated, subsequently contained oligomers are depolymerized, non-depolymerizable ...
|
|
WO/2014/206869A1 |
The present invention provides a continuous process for producing ammonium sulfate crystals, wherein said process comprises: (a) feeding to a first group of crystallization sections, which crystallization sections are heat integrated in ...
|
|
WO/2014/206862A1 |
The present invention provides a continuous process for the production of ammonium sulfate in combination with caprolactam, said process comprising, a) neutralizing with ammonia a mixture comprising caprolactam and sulfuric acid to form ...
|
|
WO/2014/111493A1 |
A method is described for linking carbon-carbon bonds by reacting carbonic acid salts with aryl, heteroaryl or vinyl alkyl sulphonates such as methane sulphonates, releasing carbon dioxide, in the presence of a bimetallic catalyst system...
|
|
WO/2014/103850A1 |
Provided is a method for producing an oxime compound with high selectivity. Provided is a method for producing an oxime represented by formula (II), which is characterized by oxidizing an amine compound represented by formula (I) (herein...
|
|
WO/2014/095807A1 |
A method is described for the production of purified caprolactam, comprising the steps: a) extraction with an organic extraction agent of raw caprolactam, obtained from the Beckmann rearrangement of cyclohexanone oxime, b) separation of ...
|
|
WO/2014/031226A1 |
Methods and systems are provided for converting methane in a feed stream to acetylene. The hydrocarbon stream is introduced into a supersonic reactor and pyrolyzed to convert at least a portion of the methane to acetylene. The reactor ef...
|
|
WO/2014/026143A1 |
Disclosed herein are synthesis methods for generation of conjugated anti-microbial compounds and conjugated anti-cancer compounds. Several embodiments, related to the uses of such compounds in the treatment of infections, in particular t...
|
|
WO/2013/152999A1 |
The present invention relates to a process for the preparation of ε-caprolactam from adipic acid, which in turn can be prepared from regenerative materials.
|
|
WO/2013/126250A1 |
Processes are disclosed for the conversion of adipic acid to caprolactam employing a chemocatalytic reaction in which an adipic acid substrate is reacted with ammonia and hydrogen, in the presence of particular heterogeneous catalysts an...
|
|
WO/2013/105343A1 |
The present invention pertains to a reaction device containing: a fluidized bed type reactor for chemically reacting a starting gas in the presence of a solid catalyst; a fluidized bed type reproducer for reproducing a portion of the sol...
|
|
WO/2013/099423A1 |
A method for producing high-quality ε-caprolactam, which comprises: a first step wherein ε-caprolactam is crystallized by evaporating an organic solvent at a reduced pressure from a mixed solution that is obtained by dissolving crude Î...
|
|
WO/2013/099425A1 |
A method for producing high-quality ε-caprolactam, comprising: a purification step of allowing ε-caprolactam to be crystallized from a mixed solution that is prepared by mixing crude ε-caprolactam produced by the Beckmann rearrangemen...
|
|
WO/2013/099426A1 |
A method for producing high-quality ε-caprolactam, which comprises: a crystallization step wherein ε-caprolactam is crystallized at a crystallization temperature of 10˚C or higher but less than melting point of the lactam from a mixed...
|
